- Trade options, futures, options on futures, stocks, ETFs
- $0 commission to close options
- Pro-grade platform and risk analysis tools
Inozyme Pharma Inc is a biotechnology business based in the US. Inozyme Pharma Inc shares (INZY) are listed on the NASDAQ and all prices are listed in US Dollars. Its last market close was $4.29 – a decrease of 10.44% over the previous week. Inozyme Pharma Inc employs 59 staff and has a market cap (total outstanding shares value) of 0.00.
Our top picks for where to buy Inozyme Pharma Inc stock
- Trade $0 commission stocks & ETFs with as little as $1
- Theme and ETF screener
- Discover new opportunities with Opto's AI-driven classification system
- Trade stocks, options, ETFs, mutual funds, alternative asset funds
- $0 commission on stocks, ETFs and options, with no options contract fees
- Complimentary access to a financial planner and automated investing
How to buy Inozyme Pharma Inc stock
- Choose a stock trading platform. Use our comparison table
- Open an account. Provide your personal information and sign up.
- Fund your account. Deposit funds into your account by linking your banking information or transfer funds from another trading account.
- Search for the stock name – INZY. Search for the stock by name or ticker symbol.
- Buy the stock. Place your order. It's that simple.
Buy Inozyme Pharma Inc stock from these online trading platforms
Compare special offers, low fees and a wide range of investment options among top trading platforms.Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.
Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.
Inozyme Pharma Inc stock price (NASDAQ: INZY)
Use our graph to track the performance of INZY stocks over time.Inozyme Pharma Inc shares at a glance
Latest market close | $4.29 |
---|---|
52-week range | $2.71 - $7.80 |
50-day moving average | $5.24 |
200-day moving average | $5.20 |
Wall St. target price | $19.00 |
PE ratio | N/A |
Dividend yield | N/A |
Earnings per share (TTM) | $-1.44 |
Is it a good time to buy Inozyme Pharma Inc stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Inozyme Pharma Inc price performance over time
Historical closes compared with the close of $4.54 from 2024-10-30
1 week (2024-10-25) | -5.22% |
---|---|
1 month (2024-10-01) | -9.56% |
3 months (2024-08-01) | -16.08% |
6 months (2024-05-01) | -1.52% |
1 year (2023-11-01) | 57.09% |
---|---|
2 years (2022-10-31) | 157.95% |
3 years (2021-11-01) | 10.3 |
5 years (2019-10-28) | N/A |
Inozyme Pharma Inc financials
Gross profit TTM | $0 |
---|---|
Return on assets TTM | -37.87% |
Return on equity TTM | -88.56% |
Profit margin | 0% |
Book value | $1.52 |
Market Capitalization | $305.3 million |
TTM: trailing 12 months
Inozyme Pharma Inc share dividends
We're not expecting Inozyme Pharma Inc to pay a dividend over the next 12 months.
Inozyme Pharma Inc share price volatility
Over the last 12 months, Inozyme Pharma Inc's shares have ranged in value from as little as $2.71 up to $7.795. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Inozyme Pharma Inc's is 1.51. This would suggest that Inozyme Pharma Inc's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).
Inozyme Pharma Inc overview
Inozyme Pharma, Inc. , a clinical-stage rare disease biopharmaceutical company, focuses on developing novel therapeutics for the treatment of vasculature, soft tissue, and skeleton diseases. The company's lead product candidate is INZ-701, a soluble, recombinant, genetically engineered, and fusion protein for the treatment of ENPP1 and ABCC6 deficiencies, as well as patients with end-stage kidney disease receiving hemodialysis. It has a license agreement with Yale University for specified therapeutic and prophylactic products. The company was incorporated in 2015 and is headquartered in Boston, Massachusetts. .
Frequently asked questions
nullWhat percentage of Inozyme Pharma Inc is owned by insiders or institutions?
Currently 0.517% of Inozyme Pharma Inc shares are held by insiders and 97.793% by institutions. How many people work for Inozyme Pharma Inc?
Latest data suggests 59 work at Inozyme Pharma Inc. When does the fiscal year end for Inozyme Pharma Inc?
Inozyme Pharma Inc's fiscal year ends in December. Where is Inozyme Pharma Inc based?
Inozyme Pharma Inc's address is: 321 Summer Street, Boston, MA, United States, 02210 What is Inozyme Pharma Inc's ISIN number?
Inozyme Pharma Inc's international securities identification number is: US45790W1080
More guides on Finder
-
Robinhood Now Let’s You Trade on the Outcome of the Presidential Election; Joining Kalshi and others.
Robinhood Launches Presidential Election Event Contracts Ahead of the Nov 5 Presidential Election
-
Today’s Best Brokerage Account Bonuses [Signup and Transfer Promos]
Explore the best bonuses for opening a new brokerage account.
-
Trading for Beginners: 9 Best Trading Platforms to Get Started
These are the best trading platforms for beginners, according to Finder’s comprehensive analysis.
-
SoFi Invest vs. Robinhood
Compare pros, cons, research tools and reviews for these two trading platforms.
-
10 Best Stock Apps of 2024 to Elevate Your Mobile Trading
Check out our picks of the best trading apps for beginners, options traders, hands-off investors and more.
-
10 Best Brokerage Accounts for Trading and Investing in 2024
See our picks of the best brokerage accounts, including Fidelity, SoFi, Charles Schwab, Public, Robinhood and E*TRADE .
-
How to invest in the S&P 500 in 2024
What you need to know about investing in the leading indicator for the overall US stock market.
-
How to Invest $10K
Maximize $10,000 with broker bonuses, IRA contribution matches, index funds, stocks, ladder CDs, hiring a financial advisor and more.
-
How to Invest $20K: 8 Ways to Maximize Earnings
Top ways to invest $20K include stocks, retirement accounts, conservative investments, ETFs and more. See our full list here.
-
Robinhood Review 2024: IRA Match and No Commissions
A deep dive into the highlights and limitations of Robinhood.
Ask a question